Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation?

Derigs P, Bethge W, Holtick U, Von Tresckow B, Ayuk F, Penack O, Vucinic V, Von Bonin M, Baldus C, Mougiakakos D, Wulf G, Schnetzke U, Stelljes M, Thomas S, Schroers R, Kroeger N, Dreger P (2022)


Publication Type: Conference contribution

Publication year: 2022

Journal

Publisher: KARGER

City/Town: BASEL

Pages Range: 169-169

Conference Proceedings Title: ONCOLOGY RESEARCH AND TREATMENT

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Derigs, P., Bethge, W., Holtick, U., Von Tresckow, B., Ayuk, F., Penack, O.,... Dreger, P. (2022). Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation? In ONCOLOGY RESEARCH AND TREATMENT (pp. 169-169). BASEL: KARGER.

MLA:

Derigs, P., et al. "Factors associated with long-term survival after failure a chimeric antigen receptor (CAR) T cell therapy for relapsed or refractory large B-cell lymphomas:a role for allogeneic stem cell transplantation?" Proceedings of the ONCOLOGY RESEARCH AND TREATMENT BASEL: KARGER, 2022. 169-169.

BibTeX: Download